Whatever way you look at it, diabetes is an expensive disease to have. Specific diets, testing equipment, specialist appointments, needles; it is an endless cycle of treatment, education, management and products.
But, for those living with Type 2 diabetes, it’s about to get a whole lot worse.
As of July 1, patients have to pay 50-times more for the box of blood-testing strips; with cuts to healthcare funding driving the price up from $1.20 to $60 for a box of 100 strips.
Bear in mind, most people living with Type 2 diabetes use these strips anywhere between four and six times a day, more so if they’re pregnant, ill, travelling, changing medications, exercising heavily, or menstruating.
It’s a change that’s set to affect a massive number of people, with almost a million Aussies suffering from Type 2 diabetes – the most common form of the disease.
Most Type 2 sufferers are not insulin dependant, but need to regularly check their blood’s glucose levels. This process involves pricking their finger to draw blood with a special lancet, and placing a small tab on the strip to get an immediate blood glucose reading.
Fair to say that now these test strips are costing 60 cents a go, many will be rethinking how often they can afford to test their blood glucose levels.
I suppose I wouldn't have noticed this news so keenly if my own boyfriend hadn't been diagnosed with Type 1 diabetes just two weeks ago.
A whirlwind of emergency room visits, specialists, needles, and 200 page manuals on living with diabetes; the diagnosis was a major shock to everyone. He is super healthy - a professional sailor - and has no family history of the disease. Unlike Type 2, Type 1 diabetes is not lifestyle related: it's random.
Top Comments
You're clearly not up with the latest on the recommended frequency of testing for stable type 2 diabetics (and by 'latest' I dont mean any of this is new). And type 1 diabetes isn't 'random' but is an autoimmune disease with strong familial connections. Stop conflating your understanding of one type of diabetes with the other.
The decision was based an a meta-analysis published in the British Jounal of Medicine. Big journal highly regarded. The point being for those on medication not insulin regular monitoring is of no benefit. In other words complete waste of time and money.